Saudi Press

Saudi Arabia and the world
Saturday, Jul 12, 2025

Go read this NYT investigation on the inaccuracy of prenatal blood tests

Go read this NYT investigation on the inaccuracy of prenatal blood tests

Blood tests on pregnant people that look for rare and devastating developmental conditions in fetuses are often wrong, according to an investigation from The New York Times.

The blood testing technology, called noninvasive prenatal testing (NIPT), works very well for more common disorders like Down syndrome. But The New York Times reported that a review of data from multiple studies showed that when NIPT is used to test for uncommon things like Wolf-Hirschhorn syndrome (which is found in one in 20,000 births) or Cri-du-chat syndrome (which is found in one in 15,000 births), positive results are wrong 80 percent of the time or more.
O
These tests, made by companies like Natera and Sequenom, have become more popular in recent years. Estimates of the size of the market approach billions of dollars. Positive results on the tests are supposed to trigger more extensive (and accurate) follow-up testing, but those tests are expensive, invasive, and often can’t be done until it would be too late for a legal abortion. Many patients don’t end up getting those follow-up tests, and some terminate pregnancies based on the initial information.

The investigation highlights the statistical challenge of testing for things that are extremely rare. Even a test that’s highly accurate would still find lots of false positives if it was used on thousands of people to try to find a condition that’s only actually there .005 percent of the time (like Wolf-Hirschhorn syndrome). It’s very difficult to create tests for rare conditions that are so good that they won’t have a high number of false positives.

But, as The New York Times reporting found, that issue wasn’t adequately explained to patients who were sold the tests. Companies developing NIPTs used language like “highly accurate” and “total confidence.” Many companies didn’t publish data on their tests’ performance overall, or only stressed data from tests that are more accurate. “I think the information they provide is misleading,” Alberto Gutierrez, the former director of a Food and Drug Administration (FDA) office overseeing medical tests, told The New York Times.

Many NIPTs don’t have to be cleared or reviewed by the FDA before they’re used for patients — they fall under a category called lab-developed tests, which are able to skirt some regulatory oversight. Despite the lack of scrutiny, they’re able to advertise to patients and tout the limited data they have in marketing materials, even if it’s misleading.

Read the full investigation here.

Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
Kurdistan Workers Party Takes Symbolic Step Towards Peace in Northern Iraq
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
AI Raises Alarms Over Long-Term Job Security
Saudi Arabia Maintains Ties with Iran Despite Israel Conflict
Russia Formally Recognizes Taliban Government in Afghanistan
Mediators Edge Closer to Israel-Hamas Ceasefire Agreement
Emirates Airline Expands Market Share with New $20 Million Campaign
House Oversight Committee Subpoenas Former Jill Biden Aide Amid Investigation into Alleged Concealment of President Biden's Cognitive Health
Amazon Reaches Major Automation Milestone with Over One Million Robots
Meta Announces Formation of Ambitious AI Unit, Meta Superintelligence Labs
China Unveils Miniature Insect-Like Surveillance Drone
Marc Marquez Claims Victory at Dutch Grand Prix Amidst Family Misfortune
Iran Executes Alleged Israeli Spies and Arrests Hundreds Amid Post-War Crackdown
Trump Asserts Readiness for Further Strikes on Iran Amid Nuclear Tensions
Iran's Parliament Votes to Suspend Cooperation with Nuclear Watchdog
Trump Announces Upcoming US-Iran Meeting Amid Controversial Airstrikes
Trump Moves to Reshape Middle East Following Israel-Iran Conflict
NATO Leaders Endorse Plan for Increased Defence Spending
U.S. Crude Oil Prices Drop Below $65 Amid Market Volatility
Explosions Rock Doha as Iranian Missiles Target Qatar
“You Have 12 Hours to Flee”: Israeli Threat Campaign Targets Surviving Iranian Officials
Oman Set to Introduce Personal Income Tax, First in Gulf
Germany and Italy Under Pressure to Repatriate $245bn of Gold from US Vaults
Iran Intensifies Crackdown on Alleged Mossad Operatives After Sabotage Claims
Trump Praises Iran’s ‘Very Weak’ Response After U.S. Strikes and Presses Israel to Pursue Peace
WATCH: Israeli forces show the aftermath of a massive airstrike at Iran's Isfahan nuclear site
We have new information and breaking details to share about what is shaping up to be a historic air campaign tonight
Six Massive Bombs Dropped on Fordow; Trump: 'A Historic Moment for the U.S., Israel, and the World'
Fordow: Deeply Buried Iranian Enrichment Site in U.S.–Israel Crosshairs
United States Conducts Precision Strikes on Iran’s Nuclear Sites
US strikes Iran nuclear sites, Trump says
Pakistan to nominate Trump for Nobel Peace Prize.
Israel Confirms Assassination of Quds Force Commander in Tehran
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
G7 Leaders Fail to Reach Consensus on Key Global Issues
Mass exodus in Tehran as millions try to flee following Trump’s evacuation order
Iranian Military Officers Reportedly Seek Contact with Reza Pahlavi, Signal Intent to Defect
Vietnam Emerges as Luxury Yacht Destination for Ultra‑Rich
China's Iranian Oil Imports Face Disruption Amid Escalating Middle East Tensions
Trump Demands Iran's Unconditional Surrender Amid Escalating Conflict
Israeli Airstrike Targets Iranian State TV in Central Tehran
President Trump is leaving the G7 summit early and has ordered the National Security Council to the Situation Room
Netanyahu Signals Potential Regime Change in Iran
Analysts Warn Iran May Resort to Unconventional Warfare
Iranian Regime Faces Existential Threat Amid Conflict
Energy Infrastructure Becomes War Zone in Middle East
Iran Conducts Ballistic Missile Launches Amid Heightened Tensions with Israel
Iran Signals Openness to Nuclear Negotiations Amid Ongoing Regional Tensions
×